Home › Funds › Vivo Capital, LLC › ACHV

Vivo Capital, LLC position in ACHV

ACHIEVE LIFE SCIENCE INC · Health Care

Vivo Capital, LLC reported holding 2,751,032 shares of ACHV (ACHIEVE LIFE SCIENCE INC) in its Q3 2026 13F filing — a position valued at US$22.3M, representing 2.53% of its reported portfolio and ranking #15 among its reported holdings. Vivo Capital, LLC has disclosed ACHV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.75M sh
Reported value held$22.26M
Portfolio Weight2.53%
First reportedQ2 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ACHV position evolved

Vivo Capital, LLC first disclosed a stake in ACHV in Q2 2026 at 2,751,032 shares (US$18.0M). The position peaked in Q3 2026 at 2,751,032 shares, worth US$22.3M. Across 2 filings, Vivo Capital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,751,032 shares valued at US$22.3M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.75M $17.96M New
Q3 2026 2.75M $22.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACHV and 13F data

ACHV (ACHIEVE LIFE SCIENCE INC) is a Health Care company. 68 other funds we track also report a position in ACHV — the largest reported positions include Frazier Life Sciences Management, L.P. (US$49.7M), TPG GP A, LLC (US$44.9M), venBio Partners LLC (US$38.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACHV

All ACHV fund holders →

FAQ

How long has Vivo Capital, LLC held ACHV?

Vivo Capital, LLC has disclosed ACHV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Vivo Capital, LLC's current position in ACHV?

As of Q3 2026, Vivo Capital, LLC holds 2.75M shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $22.26M, representing 2.53% of its reported portfolio and ranking #15.

Has Vivo Capital, LLC been buying or selling ACHV?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in ACHV. The position peaked in Q3 2026 at 2.75M shares.

Which other funds hold ACHV?

Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., TPG GP A, LLC, venBio Partners LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.